Cargando…

Change in pulmonary function tests and their relation to the serum levels of ceruloplasmin, copper and superoxide dismutase in patients suffering from Type-1 and Type-2 diabetes

OBJECTIVE: To correlate the serum levels of ceruloplasmin (Cp), copper (Cu), and superoxide dismutase (SOD) with pulmonary function tests (PFTs) in non-diabetics (controls) and patients suffering from Type-1 and Type- 2 diabetes. METHODS: The comparative cross-sectional study of 348 participants was...

Descripción completa

Detalles Bibliográficos
Autores principales: Lathiya, Nida, Aziz, Qamer, Fawwad, Asher, Siddiqui, Iftikhar Ahmed, Basit, Abdul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214808/
https://www.ncbi.nlm.nih.gov/pubmed/37250546
http://dx.doi.org/10.12669/pjms.39.3.6485
_version_ 1785047916150259712
author Lathiya, Nida
Aziz, Qamer
Fawwad, Asher
Siddiqui, Iftikhar Ahmed
Basit, Abdul
author_facet Lathiya, Nida
Aziz, Qamer
Fawwad, Asher
Siddiqui, Iftikhar Ahmed
Basit, Abdul
author_sort Lathiya, Nida
collection PubMed
description OBJECTIVE: To correlate the serum levels of ceruloplasmin (Cp), copper (Cu), and superoxide dismutase (SOD) with pulmonary function tests (PFTs) in non-diabetics (controls) and patients suffering from Type-1 and Type- 2 diabetes. METHODS: The comparative cross-sectional study of 348 participants was performed at the Baqai Institute of Diabetes and Endocrinology (BIDE) - Karachi, Pakistan, from February 2019 to September 2020. Individuals having diabetes-related complications, asthma, chronic obstructive pulmonary disease, chest infection, pregnant women and smokers were excluded. A total of 348 participants were included into three groups after signing informed consent. The control group had 107 non-diabetic participants, with an age range of 6 to 60 years. The diagnosed T1D group (n=107) had an age range of 6 to 25 years. While diagnosed T2D group (n=134) had an age range of 26 to 60 years. During the fasting state, anthropometric parameters, blood pressure, spirometry, and a venous blood sample (5ml) were collected to measure serum Cp, serum Cu, serum SOD, and HbA1c levels by using commercially available kits. The SPSS, version 21, was used for data analysis. RESULTS: The reduced FVC (p-value <0.001), FEV1 (p-value <0.001), and PEFR (p-value <0.001) were found in both groups of diabetes. However, the lower levels of serum Cu (p-value <0.001), SOD (p-value <0.001), and significantly increased values of FEV1/ FVC (p-value <0.001) and Cp levels (p-value 0.030) were found only in T2D group as compared to T1D and controls. The study found no significant correlation of PFTs and serum Cp, Cu, and SOD levels in patients suffering from T1D and T2D. CONCLUSION: Hyperglycemia leads to more non-enzymatic glycosylation of tissue proteins that reflects reduced PFTs and increased Cp; particularly in T2D, which may alter lung tissue’s physiology. Moreover, the study showed no correlation of PFTs with the Cp, Cu, and SOD in patients suffering from T1D and T2D.
format Online
Article
Text
id pubmed-10214808
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Professional Medical Publications
record_format MEDLINE/PubMed
spelling pubmed-102148082023-05-27 Change in pulmonary function tests and their relation to the serum levels of ceruloplasmin, copper and superoxide dismutase in patients suffering from Type-1 and Type-2 diabetes Lathiya, Nida Aziz, Qamer Fawwad, Asher Siddiqui, Iftikhar Ahmed Basit, Abdul Pak J Med Sci Original Article OBJECTIVE: To correlate the serum levels of ceruloplasmin (Cp), copper (Cu), and superoxide dismutase (SOD) with pulmonary function tests (PFTs) in non-diabetics (controls) and patients suffering from Type-1 and Type- 2 diabetes. METHODS: The comparative cross-sectional study of 348 participants was performed at the Baqai Institute of Diabetes and Endocrinology (BIDE) - Karachi, Pakistan, from February 2019 to September 2020. Individuals having diabetes-related complications, asthma, chronic obstructive pulmonary disease, chest infection, pregnant women and smokers were excluded. A total of 348 participants were included into three groups after signing informed consent. The control group had 107 non-diabetic participants, with an age range of 6 to 60 years. The diagnosed T1D group (n=107) had an age range of 6 to 25 years. While diagnosed T2D group (n=134) had an age range of 26 to 60 years. During the fasting state, anthropometric parameters, blood pressure, spirometry, and a venous blood sample (5ml) were collected to measure serum Cp, serum Cu, serum SOD, and HbA1c levels by using commercially available kits. The SPSS, version 21, was used for data analysis. RESULTS: The reduced FVC (p-value <0.001), FEV1 (p-value <0.001), and PEFR (p-value <0.001) were found in both groups of diabetes. However, the lower levels of serum Cu (p-value <0.001), SOD (p-value <0.001), and significantly increased values of FEV1/ FVC (p-value <0.001) and Cp levels (p-value 0.030) were found only in T2D group as compared to T1D and controls. The study found no significant correlation of PFTs and serum Cp, Cu, and SOD levels in patients suffering from T1D and T2D. CONCLUSION: Hyperglycemia leads to more non-enzymatic glycosylation of tissue proteins that reflects reduced PFTs and increased Cp; particularly in T2D, which may alter lung tissue’s physiology. Moreover, the study showed no correlation of PFTs with the Cp, Cu, and SOD in patients suffering from T1D and T2D. Professional Medical Publications 2023 /pmc/articles/PMC10214808/ /pubmed/37250546 http://dx.doi.org/10.12669/pjms.39.3.6485 Text en Copyright: © Pakistan Journal of Medical Sciences https://creativecommons.org/licenses/by/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0 (https://creativecommons.org/licenses/by/3.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Lathiya, Nida
Aziz, Qamer
Fawwad, Asher
Siddiqui, Iftikhar Ahmed
Basit, Abdul
Change in pulmonary function tests and their relation to the serum levels of ceruloplasmin, copper and superoxide dismutase in patients suffering from Type-1 and Type-2 diabetes
title Change in pulmonary function tests and their relation to the serum levels of ceruloplasmin, copper and superoxide dismutase in patients suffering from Type-1 and Type-2 diabetes
title_full Change in pulmonary function tests and their relation to the serum levels of ceruloplasmin, copper and superoxide dismutase in patients suffering from Type-1 and Type-2 diabetes
title_fullStr Change in pulmonary function tests and their relation to the serum levels of ceruloplasmin, copper and superoxide dismutase in patients suffering from Type-1 and Type-2 diabetes
title_full_unstemmed Change in pulmonary function tests and their relation to the serum levels of ceruloplasmin, copper and superoxide dismutase in patients suffering from Type-1 and Type-2 diabetes
title_short Change in pulmonary function tests and their relation to the serum levels of ceruloplasmin, copper and superoxide dismutase in patients suffering from Type-1 and Type-2 diabetes
title_sort change in pulmonary function tests and their relation to the serum levels of ceruloplasmin, copper and superoxide dismutase in patients suffering from type-1 and type-2 diabetes
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214808/
https://www.ncbi.nlm.nih.gov/pubmed/37250546
http://dx.doi.org/10.12669/pjms.39.3.6485
work_keys_str_mv AT lathiyanida changeinpulmonaryfunctiontestsandtheirrelationtotheserumlevelsofceruloplasmincopperandsuperoxidedismutaseinpatientssufferingfromtype1andtype2diabetes
AT azizqamer changeinpulmonaryfunctiontestsandtheirrelationtotheserumlevelsofceruloplasmincopperandsuperoxidedismutaseinpatientssufferingfromtype1andtype2diabetes
AT fawwadasher changeinpulmonaryfunctiontestsandtheirrelationtotheserumlevelsofceruloplasmincopperandsuperoxidedismutaseinpatientssufferingfromtype1andtype2diabetes
AT siddiquiiftikharahmed changeinpulmonaryfunctiontestsandtheirrelationtotheserumlevelsofceruloplasmincopperandsuperoxidedismutaseinpatientssufferingfromtype1andtype2diabetes
AT basitabdul changeinpulmonaryfunctiontestsandtheirrelationtotheserumlevelsofceruloplasmincopperandsuperoxidedismutaseinpatientssufferingfromtype1andtype2diabetes